Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future Prospects
Avineesh Singh(Guru Ghasidas Vishwavidyalaya), Harish Rajak(Guru Ghasidas Vishwavidyalaya), Vijay K. Patel(Guru Ghasidas Vishwavidyalaya), Surendra Jain(University Of Medicine 1 Yangon), Ravichandran Veerasamy(Guru Ghasidas Vishwavidyalaya), Prabodh Chander Sharma(Delhi Pharmaceutical Science and Research University), Preeti Patel(Indo Soviet Friendship College of Pharmacy)
Cited by 17
Related Papers
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
Understanding the role of ACE-2 receptor in pathogenesis of COVID-19 disease: a potential approach for therapeutic intervention
|Pharmacological Reports|2021|145
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141
Quinoline‐derivatives as privileged scaffolds for medicinal and pharmaceutical chemists: A comprehensive review
|Chemical Biology & Drug Design|2022|92
Alternatives of Animal Models for Biomedical Research: a Comprehensive Review of Modern Approaches
|Stem Cell Reviews and Reports|2024|85